Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.51
-0.04-1.57%
At close: -
$2.51
0.000.00%
After Hours: 4:44 PM EDT
Comments
Loading...
Aerovate Therapeutics Stock Price, Quotes and Forecasts
AVTENASDAQ
Aerovate Therapeutics (AVTE) Forecast
NewsEarningsAerovate Therapeutics (AVTE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Aerovate Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AVTE | Benzinga
Explore Aerovate Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AVTE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aerovate Therapeutics (AVTE) stock?
You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.
Who are Aerovate Therapeutics (AVTE) competitors?
Other companies in Aerovate Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Skye Bioscience (NASDAQ:SKYE), Aligos Therapeutics (NASDAQ:ALGS), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Aerovate Therapeutics (AVTE) stock?
Aerovate Therapeutics has a consensus price target of $11.75.
What is the current price for Aerovate Therapeutics (AVTE)?
The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.51 last updated March 25, 2025 at 4:44 PM EDT.
Does Aerovate Therapeutics (AVTE) pay a dividend?
There are no upcoming dividends for Aerovate Therapeutics.
When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?
Aerovate Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Aerovate Therapeutics (AVTE) going to split?
There is no upcoming split for Aerovate Therapeutics.
What sector and industry does Aerovate Therapeutics (AVTE) operate in?
Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.